Incyte (INCY) Total Debt Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26% |
| Dec 31, 2025 | 1.39% |
| Sep 30, 2025 | 3.16% |
| Jun 30, 2025 | 20.30% |
| Mar 31, 2025 | 17.63% |
| Dec 31, 2024 | 2.88% |
| Jun 30, 2024 | 0.67% |
| Mar 31, 2024 | 1.65% |
| Dec 31, 2023 | 3.83% |
| Sep 30, 2023 | 36.93% |
| Jun 30, 2023 | 37.78% |
| Mar 31, 2023 | 5.70% |
| Dec 31, 2022 | 37.65% |
| Sep 30, 2022 | 7.04% |
| Jun 30, 2022 | 10.14% |
| Mar 31, 2022 | 11.96% |
| Dec 31, 2021 | 13.63% |
| Sep 30, 2021 | 16.44% |
| Jun 30, 2021 | 17.72% |
| Sep 30, 2020 | 500.52% |
| Jun 30, 2020 | -15.42% |
| Mar 31, 2020 | -26.67% |
| Dec 31, 2019 | -16.76% |
| Sep 30, 2017 | 19.91% |
| Jun 30, 2017 | 18.67% |
| Mar 31, 2017 | 17.66% |